After consulting with a host of industry veterans and observers, our guidance recommends that you expect and plan for business disruptions and revenue declines across the board—all companies, all market segments.
The “wait and see” period for enabling technology in orthopedics is over. Commentary from executives and spending patterns of the largest orthopedic companies affirmed that message in the first three months of 2020.
The 2020 Annual Meeting of the American Academy of Orthopaedic Surgeons (AAOS) is canceled due to the ongoing spread of coronavirus. ORTHOWORLD wishes to reiterate our commitment to keep Members and subscribers apprised of the announcements to follow over the coming weeks.
In anticipation of leveraging conversations with surgeons at AAOS' Annual Meeting, this column focuses on major trends reshaping the device company and provider relationship. Each of these trends represent opportunity for orthopedic companies.